Fred Gluck is Chairman and CEO of CytomX a newly founded venture to exploit micro fluidics in cell sorting and related areas. He is a former managing director of McKinsey & Company, Inc., the international management consulting firm. He served with McKinsey from 1967 to 1995 and led the firm as its Managing Director from 1988 to 1994, when he retired from the Firm to join The Bechtel Group, where he served as Vice-Chairman and Director. Mr. Gluck retired from Bechtel in July 1998. He rejoined McKinsey and Company as a consultant to the firm in 1998 and continued in that role until July 2003.
Mr. Gluck earned a bachelors degree in electrical engineering from Manhattan College and a masters degree in the same field from New York University. In addition, he did graduate studies in operations research at Columbia University. He holds an honorary doctorate from Hofstra University.
Mr. Gluck serves on the board of directors of AMGEN (Thousand Oaks, CA) [NASDAQ].
Mr. Gluck also serves as Director of a number of eleemosynary organizations, including the Cottage Health System (Santa Barbara, Ca) and The New York Presbyterian Hospital. He was Vice-Chairman of New York Hospital, prior to its merger with Columbia Presbyterian and is currently Vice-Chairman of the Cottage Health System. He is also active at University of California, Santa Barbara, where he is a trustee of the UCSB Foundation, a member of the Advisory Council of the Kavli Institute of Theoretical Physics, and a member of the Steering Committee for the Campaign for UCSB. Additionally, Mr. Gluck serves on the Board of Advisors of RAND Health in Santa Monica, CA. and Tennenbaum Capital Partners in Los Angeles, California and the Brookings Budgeting for National Priorities Corporate Advisory Committee.